Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence

Clin Oncol (R Coll Radiol). 2024 Sep;36(9):534-536. doi: 10.1016/j.clon.2024.05.007. Epub 2024 May 15.
No abstract available

Keywords: Chemotherapy; head and neck cancer; immunotherapy; pembrolizumab.

Publication types

  • Letter
  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • England
  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Palliative Care* / methods

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab